ATRX and neuroblastoma: In summary, loss of Atrx in Th-expressing cells is not sufficient to drive neuroblastoma in mice, suggesting that either ATRX mutations may occur at a different timepoint during embryo development and/or additional events are required to drive tumorigenesis.